Design, Syntheses, and in Vitro Evaluation of New Fluorine-18 Radiolabeled Tau-Labeling Molecular Probes

J Med Chem. 2017 Nov 9;60(21):8741-8757. doi: 10.1021/acs.jmedchem.7b00764. Epub 2017 Oct 2.

Abstract

Deposition of aggregates of hyperphosphorylated tau protein is a hallmark of tauopathies like Alzheimer and many other neurodegenerative diseases. A sensitive and selective method of in vivo detection of tau-aggregate presence and distribution could provide the means of an early diagnosis of tau-associated diseases. Furthermore, the use of selective molecular probes that enable histochemical differentiation of protein aggregates post-mortem would be advantageous for the insight into the properties of tau protein aggregates. We chose to design new molecular probes based on the structure of 2-(1-(6-((2-[18F]fluoroethyl)(methyl)amino)-2-naphthyl)ethylidene)malononitrile to investigate their likelihood of fitting into VQIVYK tau protein binding channel model. In a modular approach, using cross-coupling reactions, we synthesized a series of candidates, radiolabeled them with fluorine-18 radioisotope, and determined their physicochemical and in vitro binding properties. Herein we report the synthesis of a series of molecular probes capable of detection of tau protein deposits in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Drug Design*
  • Fluorine Radioisotopes
  • Humans
  • Isotope Labeling
  • Molecular Probes / chemical synthesis*
  • Nitriles / chemistry
  • Tauopathies / diagnosis*
  • tau Proteins / analysis*

Substances

  • Fluorine Radioisotopes
  • Molecular Probes
  • Nitriles
  • tau Proteins
  • dicyanmethane